2025 Registration will open soon!
La Cantera Resort & Spa
San Antonio, TX
Overview
Calling all self-care industry decision-makers! Don't miss the 2025 Annual Self-Care Leadership Summit, where innovation meets inspiration. Connect with like-minded leaders, exchange ideas, and forge meaningful collaborations. Join the self-care revolution, shape the industry's future, and lead with purpose. Don't wait, secure your spot today at this extraordinary summit!
"Under the guidance of CHPA, the Annual Meeting is where companies come together to navigate industry & category wide issues."
"If you are a key player in the consumer healthcare space, taking advantage of being in an environment where competitors come together as collaborators is imperative."
2025 SLS Program - As of 11.12.24 (Subject to Change)
March 17-19, 2025
Monday, March 17, 2025
12:00 - 4:00 p.m.
Golf Tournament and Activities
11:00 - 5:00 p.m.
Registration
Tuesday, March 18, 2025
Coming Soon!
Wednesday, March 19, 2025
Coming Soon!
Speaker Bios
With an impressive lineup of confirmed speakers, this summit promises to be a game-changer for professionals in the field. Get ready to be inspired, enlightened, and equipped with the latest insights and strategies to lead the self-care industry into the future.
Scott Gottlieb is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. He serves on the boards of Pfizer Inc. and Illumina, Inc., is a resident fellow at the American Enterprise Institute and a partner at the venture capital firm New Enterprise Associates.
Dr. Gottlieb is an aggressive advocate for advancing the health of patients, promoting healthcare access, and driving innovation. The agency’s historic and prolific advances in new policy distinguished his tenure as the FDA’s commissioner, in addition to a record-setting number of approvals of novel drugs, medical devices, and generic medicines. Under his leadership, the FDA advanced new frameworks for the modern and safe and effective oversight of gene therapies, cell based regenerative medicines, targeted drugs, and digital health devices. The FDA implemented new reforms to standardize drug reviews and make historic improvements of post market data collection and the use of real-world evidence. They promoted policies to reduce death and disease from tobacco, improve food safety, and aggressively confront addiction crises.
Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he helped advance policies to improve healthcare quality and promote the effective use of new medical technologies. Dr. Gottlieb is widely published in leading medical journals and periodicals, including The Wall Street Journal, The New York Times, and The Washington Post. He has held editorial positions on the British Medical Journal and the Journal of the American Medical Association and is a regular contributor to CNBC. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019. In 2018, 2019 and then again in 2020 Modern Healthcare named Dr. Gottlieb the “Most Influential Physician Executive and Leaders” in its annual survey of 50 physician executives, and Time magazine named him one of its “50 People Transforming Healthcare in 2018.” Dr. Gottlieb is also the author of New York Times Bestseller Uncontrolled Spread: Why COVID-19 Crushed Us and How We Can Defeat the Next Pandemic.
Dr. Gottlieb was a practicing hospitalist, and he is an elected member of the National Academy of Medicine. He lives in Westport, Connecticut with his wife and three daughters.
Michael Arlotto is the Global Head of Corporate Development and Ventures at Kenvue. In this role, Michael drives Kenvue’s inorganic strategy including leading Kenvue’s M&A activities, early-stage investments and partnerships across all regions and segments.
Prior to joining Kenvue, Michael held the position of Senior Vice President and General Manager at Miller-Knoll. Michael joined Miller-Knoll as part of Knoll's merger with Herman Miller and served as Knoll integration lead. Michael was responsible for M&A including identifying and driving growth opportunities across a portfolio of brands, businesses, and geographies and new business development across Knoll and General Manager for Knoll’s conference business. Prior to that, Michael held leadership roles at The Estée Lauder Companies within Corporate Development as well as marketing at Clinique. Previously, Michael held leaderships roles at Barclays Capital, Lehman Brothers, Standard & Poor’s, and Arthur Andersen.
Michael has an MBA from Harvard Business School as well as a Bachelor’s degree in Business Economics from the University of California, Los Angeles. He currently lives in New York and is an active Board Member of Brooklyn Community Pride Center, which provides services and support to the borough’s LGBTQ+ community.
Musab Balbale is SVP and Chief Merchant at CVS Health. He is responsible for merchandising, the retail digital experience, and store formats, for the CVS front store. Musab has over 20 years of consumer and retail experience and joined CVS in 2022.
Most recently, Musab was Merchandising Vice President of Beauty at Walmart. In that role, he led the transformation of Walmart’s omni-beauty business across stores and ecommerce. He led the team to create innovative, new beauty experiences and increased industry awareness and consumer perception of Walmart Beauty. Prior to that role, Musab led Walmart’s Health, Beauty and Pharmacy business for Walmart eCommerce. He joined Walmart through its acquisition of Jet.com in 2016, where he was the General Manager of Jet’s pet business.
Prior to Jet and Walmart, Musab was the Vice President of Business Development and International for The Vitamin Shoppe. In that capacity, he led the expansion of Vitamin Shoppe into international markets including Canada, Central and Latin America.
Musab’s earlier career includes strategy at The Boston Consulting Group and at Charles Schwab; and in Private Equity at Summit Partners where he focused on the consumer and retail sectors. Musab has a BA from Yale University and an MBA from Harvard Business School.
Grace Bandong is the Business Unit Manager for Contaminants for Eurofins Food Chemistry Testing (EFCT). Grace has spent over 30 years in the food and supplement industry specializing in contaminants analysis including elemental analysis, pesticide residue analysis and risk assessments. Over the years, Grace has developed contaminant-testing programs that support supplier verification for food manufacturers and recently, the hemp industry. Grace developed a process for a hazard based chemical risk assessment of ingredients that is used as a guide by companies to respond to global regulatory requirements. She is an expert chemical risk assessment for dietary supplements and food.
Grace’s role at EFCT is to oversee a team of scientists in routine analytical testing and method development. Over the last few years, her team has developed methods for emerging contaminants of concern to the infant formula, dietary supplements and botanicals markets including ethylene oxide, PFAS and adulterants in weight loss, sports nutrition, and male enhancement supplements. Grace and her team have also developed methods for the Hemp industry and EFCT in Madison was one of the first laboratories in the country to meet the Colorado Department of Health and Environment’s very stringent requirements for pesticide residue screening.
Grace earned her degree in Chemistry from the University of the Philippines and her MSc in Chemistry from the University of Houston.
Shaun is a Partner at McKinsey & Company and leads McKinsey’s consumer health practice. Passionate about helping companies better meet consumers’ needs to improve their health and wellness, Shaun has worked in the Consumer Health space for over a decade. In this context, Shaun has worked with a range of companies to advance this mission, including consumer packaged goods manufacturers, retailers, start-ups, private equity sponsors, providers, and life sciences and diagnostics companies. Shaun founded McKinsey’s consumer health practice and has led several initiatives to increase industry awareness and knowledge, including McKinsey’s annual “Future of Wellness” consumer insights. Shaun’s work focuses on strategy, M&A, growth, and organizational design, working primarily with consumer health and consumer packaged goods companies. Over his career, Shaun has supported consumer health companies in multiple ways. Recent work includes:
- Leading the integration of a large-scale consumer health acquisition;
- Helping a consumer health company expand its diagnostics portfolio;
- Leading the vitamins and naturals strategy for a consumer health player;
- Helping a life sciences player with its digestive wellness expansion strategy;
- Creating a 10-year strategy for a consumer health focused contract manufacturer;
- Supporting a consumer health company in simplifying and streamlining its global organization;
- Leading 10+ acquisition due diligence processes in the past two years.
Shaun has been a CHPA member for four years. Prior to joining McKinsey, Shaun worked at UBS Investment Bank, where he covered the consumer sector and supported companies on strategic transactions. He is a graduate of Princeton University and holds a Master of Business Administration from Columbia Business School. He lives with his wife and three children (who are under the age of six) in New Jersey.
Kathryn Chovanes is the Chief Client Officer at Let There Be, a healthcare video marketing agency that helps brands communicate and utilize their greatest asset: their science! Kathryn joined Let There Be in its infancy and her focus has always been the clients. She developed the processes and strategies for both acquiring clients and for giving them an unforgettably positive agency experience. Kathryn has been instrumental in expanding Let There Be's capabilities, and she also leads industry involvements.
Prior to joining Let There Be in 2014, Kathryn worked at Pfizer Consumer Healthcare in brand marketing. Kathryn also founded and is the Executive Director of EVAC (evacoperation.org), a 501c3 non-profit that protects, evacuates, and re-settles US-Affiliated Afghan Allies who are now facing Taliban threat. Under her leadership, EVAC has helped hundreds of US Allies evade the Taliban and make it safely to new countries for resettlement. Kathryn lives in Colorado with her dogs and enjoys hiking, skiing, and Colorado’s yearly 300 days of sunshine.
Ryan Fagan is a Managing Director at Gryphon Investors, where he leads the firm’s investments in consumer health and wellness. Gryphon Investors is a leading private equity firm with approximately $9 billion of assets under management. Ryan joined Gryphon in 2007, and has been actively engaged in the consumer health sector continuously for over a decade. In that time, Gryphon has made three successful control investments in the industry, including Fleet Laboratories, which was sold to Prestige Consumer Healthcare in 2016; Matrixx Initiatives / Zicam, which was sold to Church and Dwight in December 2020; and, most recently Metagenics, which Gryphon acquired in November 2021. Metagenics is leading global practitioner-recommended nutritional supplement brand with the mission of helping people live happier, healthier lives. Ryan is passionate about discovering and partnering with businesses and management teams who help consumers proactively address their health and wellness needs with safe effective product solutions. He continues to actively assess new investment opportunities in the consumer health category today, including in nutritional supplements, OTC medicines, medical devices, and adjacent categories of personal care.
Prior to joining Gryphon, Ryan worked as an Investment Banker with Merrill Lynch in the consumer and retail group. He holds a B.S. in Economics from The Wharton School at the University of Pennsylvania and a J.D. from Columbia Law School. He lives in Menlo Park, CA with his wife, a physician, and their two daughters.
John is Executive Vice President, Consumer with Bausch + Lomb, a leading global integrated eye health company. Driven by a passion for helping people lead healthier lives, he is energized by building enduring health care brands fueled by innovation, that empower consumers, patients, and providers while creating value through better health outcomes.
Previously, John was General Manager of the Vision Care business unit of Bausch + Lomb. Under his leadership, the team launched several innovative first-in-class or best-in-class new products including Bausch + Lomb INFUSE daily disposable contact lenses and ULTRA Multifocal for Astigmatism lenses.
Over his career, he has successfully led U.S. and global marketing teams at Bausch + Lomb, Becton Dickinson (BD), and Wyeth helping build leading brands such as Advil, Centrum, ChapStick, Pristiq, PreserVision and Ocuvite. John recognizes the importance of sustainability to health and is proud of his teams’ association with the first manufacturer sponsored recycling programs to reduce the impact of microplastics for contact lenses and disposable medical sharps.
As part of John’s dedication to better health, he serves on the National Board of Directors of Prevent Blindness, the nation’s oldest organization dedicated to bringing Americans to eye care and the Board of the Consumer Healthcare Products Association (CHPA). He is a graduate of Ohio University and holds a Master of Business Administration from the Fisher College of Business at The Ohio State University (Go Bucks!).
Sherry Frey brings more than two decades of industry experience to her role as Vice President, Total Wellness at NielsenIQ. With a background in market research, innovation and consulting, she has elevated clients across the fresh, CPG and wellness industries, providing forward-thinking insights, combined with practical strategies. In addition to leading NielsenIQ’s Total Wellness team and industry engagement, Sherry has been a featured speaker at many national and international industry events and is often sought as a media and analyst resource on topics related to consumer health, wellness and environmental issues. Sherry’s view of health and wellness spans beyond personal health and wellness, encompassing how we collectively think about the health of the planet.
Alex Gelbert founded the video marketing agency Let There Be in 2013 with the vision of empowering healthcare brands to be bold with their science. He believes that educated consumers buy products, informed retailers put products on shelf, and engaged HCPs recommend products to their patients. Seeing other agencies lacking this capability, Let There Be came onto the scene with a bang: leading the consumer education campaign for the Nexium 24HR Rx-to-OTC switch.
As CEO of Let There Be, Alex leads a small agency that’s helped many of the world’s best healthcare brands explain their science, including Advil, Centrum, Viagra, Lotrimin, and many more. Over the years, Alex expanded the agency to include new capabilities such as developing comprehensive video marketing campaigns with video ads, social media video, and explainers.
Outside of Let There Be, Alex serves as Treasurer of EVAC, a 501c3 non-profit that protects, evacuates, and re-settles US-Affiliated Afghan Allies who are now facing Taliban threat. Alex lives in Colorado where he enjoys competing in amateur car racing leagues, reading, and spending time with friends and family.
Lance Goodridge is an Executive in IRI’s Global Analytics & Insights solutions area. With more than 25 years of experience, Lance is an expert in Analytics and Marketing consulting and has worked with a variety of companies prior to IRI including Accenture, Marketing Management Analytics and The Cambridge Group.
His expertise includes commercial spend effectiveness and automated solutions, with particular emphasis on marketing mix, digital media solutions, in-store execution, forecasting, revenue growth management, retailer/class of trade strategies, pricing optimization and architecture. He also focuses on brand and business insights and strategy development.
Fred Hassan is a Director with the private equity firm, Warburg Pincus. Hassan’s public boards include Precigen, Cocrystal Pharma, and BridgeBio. Fred Hassan is the former Chairman of the Board and Chief Executive Officer of Schering-Plough Corporation. Prior to joining Schering- Plough in April 2003, Hassan was Chairman and Chief Executive Officer of Pharmacia Corporation – a company that was formed in March 2000 from the merger of Monsanto and Pharmacia and Upjohn. Hassan joined Pharmacia & Upjohn as Chief Executive Officer in 1997. Previously, Hassan was Executive Vice President of Wyeth, with responsibility for its global pharmaceutical and medical products business. He was elected to Wyeth's Board of Directors in 1995. Earlier in his career, Hassan spent 17 years with Sandoz.
Pharmaceuticals (now Novartis) and became CEO of its US division. Hassan received a B.S. degree in chemical engineering from the Imperial College of Science and Technology at the University of London and an M.B.A. from Harvard Business School. Hassan continues to coach senior executives and CEOs. In 2014, a CNBC panel named Hassan to a list of those who have had the most profound impact on the world of business in the previous quarter century.
Mr. Hood is a Managing Director and Founder of William Hood & Company, a differentiated industry-focused investment bank covering the Consumer, Food and Retail sectors.
Mr. Hood is well-known globally as a leading investment banker to the Consumer Products and Health & Wellness industries having led or been involved in many of the larger and better-known transactions including the sale of Bonafide to Pharmavite for $425 million, YouTheory to Jamieson, the sale of Metagenics to Gryphon, the sale of VÖOST to Procter & Gamble, the sale of Welly to Unilever, the sale of Jarrow to New Mountain Capital, the sale of Liquid I.V. to Unilever, the sale of Persona to Nestlé, the sale of OLLY to Unilever, the sale of GNC’s Nutra manufacturing subsidiary to IVC, the sale of Atrium Innovations (Garden of Life) to Nestlé for $2.4 billion, the sale of The Nature’s Bounty Company from The Carlyle Group to KKR for $3.0 billion, the sale of U.K.-based Holland & Barrett to Letter1 Retail for $2.3 billion, the sale of Unipharm to Takeda, the sale of Iovate to Xiwang (China) for $850 million, the sale of Jamieson to CCMP, the sale of Santa Cruz Nutrition to RoundTable Healthcare Partners, the sale of Schiff to Reckitt Benckiser for $1.4 billion, the sale of Avid Health (Lil’ Critters and Vitafusion) to Church & Dwight for $650 million, the purchase of Airborne by Schiff Nutrition and the sale of Emergen-C to Pfizer for $350 million, among others.
Prior to launching William Hood & Company, Mr. Hood spent 8 years as a Managing Director at Houlihan Lokey (HL) where he founded, built and led the firm’s Consumer Health and Wellness practice. Prior to joining HL, Mr. Hood spent 9 years at a highly specialized investment banking boutique, a firm he joined at inception and where he became a Partner focused on transactions in the Consumer industry. Mr. Hood began his career 27 years ago at PaineWebber Investment Banking in New York.
Widely regarded as an expert in the industry, Mr. Hood is frequently invited to speak about M&A at key Health and Wellness conferences including CHPA, Expo West, Expo East, the NBJ Summit and Supply Side West. Mr. Hood is also a contributor to both industry and financial publications and has been published or quoted about industry trends and matters of M&A in the Wall Street Journal, Bloomberg, WWD and on CNBC among others. Mr. Hood serves on the Editorial Board of the Nutrition Business Journal.
Mr. Hood has a global network and travels frequently to Europe and Asia. He grew up in the U.K. and Hong Kong and holds a B.S. from Georgetown University.
Mr. Hood serves on the Board of Directors of Vitamin Angels, the Board of Trustees of Vitamin Angels U.K. and the Board of Greenwich Emergency Medical Services in Greenwich, CT.
As the EVP & Practice Leader of Wellness and Homecare at Circana, Kristin Hornberger plays a vital role in driving success and forging strategic partnerships with global clients, delivering invaluable insights and growth opportunities.
With an impressive career spanning over two decades, Kristin has become a trusted expert in healthcare, nutritionals, skincare, and home. She leverages her deep industry knowledge to support a global clientele, enabling her clients to make informed decisions and stay ahead in a competitive landscape. Her expertise extends to evaluating new products and challenger brands, especially among digitally native brands migrating into the brick & mortar space, where she excels in identifying emerging trends and opportunities.
In her Wellness & Homecare role, Hornberger is responsible for generating industry thought leadership, uncovering client growth opportunities, leading the transformation of client insight capabilities, and fusing disparate data sources into one strategic approach.
Kristin's industry leadership and expertise are further evidenced by her role as a board member of the Consumer Healthcare Products Association (CHPA). Her strategic approach has positioned her as an industry thought leader creating lasting impact, empowering companies to build strong brand presence.
Christin is an Associate Principal and leader of the Consumer Health Practice at ZS. She has extensive experience in business strategy, portfolio management, brand development, uncovering consumer insights, product innovation, shopper journey & marketing, and market research and analytics. Her focus at ZS includes working with consumer health clients on AI-driven insights generation, brand strategy, innovation, and personalization. She has also advised small businesses on go-to-market strategy and DTC sales and marketing best practices. Prior to joining ZS, Christin worked 20+ years at multinational CPG and Consumer Health companies including Procter & Gamble, Reckitt, and Novartis Consumer Health. She has global project experience managing brands across North America, Europe, and Asia, and spent time living in Russia, Japan, and Spain.
Slava serves as Managing Director and Co-Head of U.S. Consumer Investment Banking at CG Sawaya Partners. Slava’s career has been dedicated to the industry and he is actively involved in advising public companies, private companies and financial sponsors on a variety of sell-side, buy-side and corporate divestiture transactions across the consumer health space globally.
Just recently, Slava has advised on a number of notable industry transactions, among them the sale of HRA Pharma to Perrigo, the acquisition of Akorn’s consumer health business by Prestige Consumer Healthcare, the sale of LifeStyles Healthcare to Linden Capital Partners, the sale of Nature’s One to Bobbie, the sale of Advantice Health to TA Associates, the sale of Wellspring Consumer Healthcare to Avista Capital Partners, the sale of Focus Consumer Healthcare to Kobayashi, the acquisition of Arcadia Consumer Healthcare by Bansk Group, the acquisition of E45 by Karo Pharma from Reckitt and the acquisition of Astroglide by Combe.
Slava actively engages with the industry community as member, speaker and thought leader at various industry events around the world.
A highly respected political journalist, Jonathan Martin provides sought-after coverage and regularly drives the news by delivering the inside story from the White House and Capitol Hill to the campaign trail well beyond the beltway. As bureau chief and senior political columnist for POLITICO, Martin is among the most trusted reporters in the country with deep connections to the political leaders, power players, and movers and shakers in Washington, D.C. — and across the country. With vast array of sources in both parties and his keen analytical mind, he reveals what’s really happening at the highest levels of American politics.
Exclusively represented by Leading Authorities speakers bureau, Martin is a throwback to the golden age of journalism rooted in reporting the cold, hard facts while exploring beyond the headlines to provide a full picture of what’s happening in politics today and how it’s shaping the future of business and society. Combining his encyclopedic knowledge of political history with unparalleled insight into the hot-button issues of the day and an unmistakable enthusiasm for politics at every level, Martin leads a deep dive into today’s top news stories while discussing the potential impact of emerging trends in government, politics, and policy. With extensive relationships on both sides of the aisle — in Washington, D.C., state capitols, and city halls — Martin possesses a flesh-and-blood understanding of what’s at play for the future of politics, which is complemented by fascinating, firsthand anecdotes gleaned from rubbing elbows with the key players.
Prior to assuming the role of politics bureau chief and senior political columnist at POLITICO, Martin was the senior political correspondent for The New York Times, serving as the publication’s top political reporter for nearly a decade. Before that, he was the senior political writer for POLITICO, where he was among the company’s first hires and is regarded as one of its “originals.” Martin also worked as a political reporter for National Journal’s “The Hotline” and National Review. He is the co-author of This Will Not Pass: Trump, Biden, and the Battle for America’s Future, which spent three weeks on The New York Times bestseller list and, with its never-before-heard audio recordings, gave readers fly-on-the-wall access to some of the most important political conversations of our time.
Martin is a dynamic voice in print and broadcast who audiences will recognize as a longtime CNN analyst. His work has been featured in The New Republic, The Washington Post, and The Wall Street Journal, as well as many more of the nation’s leading publications. He is renowned in journalism circles for his leadership in the newsroom, as well as his commitment to upholding the integrity of journalism and advancing the potential to tell news stories more authoritatively and creatively.
Kyle is a Consultant within ZS’ Consumer Practice. He leverages AI tools to unlock deep consumer insights, fueling product innovation, product messaging and marketing, and shaping brand strategy. Kyle has worked across the consumer health, consumer durables, hospitality, and financial services industries, focused on helping clients understand demand and development strategies to win in competitive markets. Prior to joining ZS, Kyle received an MBA in Financial Technology from Fordham’s Gabelli School of Business and served as an officer in the United States Army.
Brian is CEO of Haleon plc, a company with a single-minded focus on improving everyday health and a portfolio of some of the world’s most trusted and best-selling brands including Sensodyne, Voltaren, Advil and Centrum.
Brian has led Haleon, formerly GSK Consumer Healthcare, since 2016 and is focused on shaping a strategy for growth that puts purpose at its heart. He leads 23,000 employees across more than 100 countries, who are working every day to deliver better everyday health with humanity.
Brian initially joined GSK Consumer Healthcare as Head of Europe and the Americas in 2015, Previously, he spent three years as the Over-the-Counter (OTC) Division Head at Novartis and a member of the Novartis Executive Committee, following a number of senior leadership roles across his ten-year tenure at the company. He began his career at Procter & Gamble, where over a 16-year tenure, he gained extensive experience in product supply, brand marketing, and customer leadership.
Brian sits on Haleon’s Board of Directors. He is also a Board member of the Consumer Goods Forum (CGF) and has previously served as a Board Member and Chairman of the Global Self Care Federation (GSCF). Previously, he was an active member of the Board of Trustees for Treloar’s – a trust providing support and independence education for young people with physical disabilities. For Brian, authenticity, courage, and inclusion as fundamentals to great leadership and outside of work he enjoys spending time with his wife and daughters and is an exercise enthusiastic; particularly running, skiing, and cycling.
Scott Melville is the president and chief executive officer of CHPA and leads the organization’s efforts to empower consumer self-care by preserving and expanding choice and availability of consumer healthcare products, including OTC medicines, dietary supplements and consumer medical devices.
Prior to joining CHPA, Melville served as senior vice president of government affairs and general counsel for the Healthcare Distribution Alliance (formerly HDMA), representing pharmaceutical wholesale distributors.
Melville previously served in various public affairs and legal roles for the pharmaceutical and biotechnology companies Sterling-Winthrop, Hoffmann-LaRoche, and Cephalon. Melville began his professional career as a legislative assistant and appropriations committee associate on the staff of retired U.S. Congressman Jerry Lewis (R-Calif.).
He earned his bachelor’s degree in economics and political science from Bucknell University, and his juris doctorate from George Mason University’s Antonin Scalia School of Law. He serves on the boards of the Global Self-Care Federation, and the Health in Hand Foundation.
Lindsay Morris is a Director of Federal Affairs as part of Bayer’s Public Affairs, Science and Sustainability (PASS) division. She works as part of Bayer’s government affairs team as lead liaison to Bayer’s U.S. Consumer Health division, including over the counter (OTC) medications and dietary supplements such as Bayer Aspirin, Aleve, Claritin, One-A-Day and Flintstones Vitamins. She also coordinates with the broader Bayer healthcare policy team on issues related to the company’s prescription drug and radiology businesses.
Prior to her current position, Lindsay was Head of Federal Affairs for the Consumer Healthcare Products Association (CHPA), the trade association for manufacturers of OTC medications, dietary supplements, and consumer medical devices. She was also head of Federal Affairs for the Medical Imaging & Technology Alliance (MITA), which represents the leading manufacturers of medical imaging equipment.
Lindsay began her career on Capitol Hill working for then-Senator Mike DeWine (R-OH) on the Health, Education, Labor & Pensions (HELP) Committee and for Senator Gordon Smith (R-OR) on the Senate Special Committee on Aging.
Lindsay is a graduate of Georgetown University with a bachelor’s degree in economics and master’s degree in public policy (MPP).
Lisa leads the North America Region for Haleon, currently the largest Consumer Health company in the world.
As President, she is a member of the Executive Leadership Team and responsible for helping guide the enterprise and oversee the business unit across brand management, customer and expert sales, and more. Under her leadership, the North American business builds business opportunities across numerous health and wellness categories encompassing brands such as Advil, Centrum, Emergen-C, Flonase, Paradontax, Sensodyne, Theraflu and Tums.
She joined the company in 2019 from Pfizer Consumer Healthcare, where she had been President of North America. In her decade at Pfizer, Lisa held senior roles in sales strategy; was General Manager of Puerto Rico & Caribbean; and was the U.S. Chief Customer Officer and Global E-Commerce leader.
Previously, Lisa worked at Johnson & Johnson as a Vice President in US Sales and also spent 18 years with the former Pfizer Consumer Healthcare/Warner Lambert where she held positions of increasing responsibility in Sales, Customer Development, Operations, Category Management & Insights and General Management.
Lisa is a former Certified Public Accountant and worked for Deloitte. She earned her Bachelor of Science in Accounting at Miami University and her Executive Master of Business Administration at The Ohio State University.
Lisa is a Board member of several US industry association boards including CHPA Executive Committee, NACDS Retail Advisory Board and the WE Board. She was named Chair-Elect of the CHPA Board of Directors and will assume the position in 2023, and most recently, was named Executive of the Year by New Jersey Business Magazine.
Rusty is a managing partner at Alantra and head of the US healthcare practice. He has over 15 years of M&A experience and is focused exclusively on healthcare investment banking. His client list ranges from large pharmaceuticals to early-stage drug development companies, as well as many service companies. Prior to joining Alantra, Rusty was a managing director at Crosstree Capital Partners, a health science investment bank, a deputy director at a Washington D.C.-based think tank, and he worked with the Meningitis Research Foundation in London. He was also a member of the Board of Directors for Apricus Bio (NASDAQ: APRI). Rusty holds an MBA from Fordham University and received a BS in Biology from Wake Forest University.
Ms. Roddy is a senior member of Houlihan Lokey’s Consumer, Food & Retail Group, leading the firm’s Consumer Health and Personal Care practice. She specializes in Health & Wellness, including OTC, nutritional supplements, women’s health and sexual health & wellbeing. With over two decades of corporate finance experience, Ms. Roddy is well regarded as a leading advisor to high growth consumer brands.
Her recent work includes the sales of Thinx to Kimberly Clark, Lifestyles to Linden Capital, Arcadia Consumer Health to Bansk Group, Zesty Paws to H&H Group, Nuun to Nestlé Health Science, SmartyPants to Unilever, Care/of to Bayer, and Zarbee’s to Johnson & Johnson. She also has significant expertise in corporate carve-outs and divestitures, as well as contract manufacturing and private label across sectors.
Before joining Houlihan Lokey, Ms. Roddy worked in Corporate Strategy & Development at PepsiCo, where she led deal execution in Europe and was responsible for executing the company’s strategy to expand into good-for-you and better-for-you food & beverage categories. Prior to that, she worked in Investment Banking for Deutsche Bank and as an accountant for Ernst & Young.
Ms. Roddy holds a B.S. in Accounting from Bucknell University and an MBA from the Darden School at the University of Virginia. She was previously a Certified Public Accountant in the state of Pennsylvania (expired).
Brent Saunders is a visionary leader and one of the most successful value creators in the history of health care. As the CEO and Chairman of Bausch + Lomb, Brent oversees a team of approximately 13,000 people who deliver innovative solutions to protect and enhance the gift of sight for millions of individuals worldwide.
He has been the driving force behind numerous health care and pharmaceutical mega deals that have resulted in tremendous benefits for patients, shareholders and employees. These include Allergan plc.’s $63 billion acquisition by Abbvie Inc, Forest Laboratories Inc.’s $25 billion merger with Actavis plc and Actavis’ $66 billion acquisition of Allergan.
Brent is a sought-after advisor and industry thought leader. He has served on the boards of companies ranging from early-stage innovators to established brands including Cisco Systems, Inc. He currently serves as the Chairman of the Board of The Beauty Health Company and as a director of ARS Pharmaceuticals, Inc. He is also on the Executive Committee of Mt. Sinai Medical Center.
Marc Schloss heads the Federal Government Affairs team and is responsible for developing and implementing federal lobbying strategies on behalf of CHPA and its member companies.
Prior to joining CHPA, Schloss served as Senior Director, Federal Government Affairs at Mylan N.V., the largest manufacturer of generic medications in the nation.
Schloss began his career in the office of Senator Edward M. Kennedy as a Legislative Aide and proceeded to a series of increasingly responsible positions with the Democratic National Committee, Senator Evan Bayh's Political Action Committee, Van Scoyoc Associates, Inc., the Center for American Progress, and the National Association of Chain Drug Stores before assuming his role at Mylan, where he led Congressional outreach efforts on behalf of Mylan.
Ms. Staib is a Managing Director and Partner of William Hood & Company, a differentiated industry-focused investment banking firm covering the Consumer, Food and Retail sectors with a specialization in Health and Wellness.
Prior to William Hood & Company, Jill was Vice President of Strategic Initiatives for The Nature’s Bounty Company, the largest pure-play manufacturer and marketer of health and wellness products in the world with over $3 billion in annual revenue. Her global role focused on M&A, Corporate Development and Growth Strategy. In this capacity, she led a variety of global projects for the company including the sale of The Nature’s Bounty Company from The Carlyle Group to KKR and the sale of U.K.-based retailer Holland & Barrett from The Carlyle Group to Letter1 Retail. Jill was also involved in the acquisitions of natural personal care brand Dr. Organic, leading bar brand Best Bar Ever, as well as in the company’s joint venture with By-Health in China.
During her tenure at The Nature’s Bounty Company, Jill also held a variety of operating leadership roles including managing the Nature’s Bounty, Pure Protein, Body Fortress and Met-Rx brands, as well as the company’s Private Label business. Jill’s passion for brands combined with her retailer relationships resulted in her driving a number of the key strategic growth initiatives behind the success of the company leading up to its sale. While managing the Nature’s Bounty brand, Jill successfully created and launched the Optimal Solutions line including its flagship Hair, Skin and Nails product, the current market leader in women’s health supplements and the fastest growing line extension in the company’s history with over $100 million in revenue. She was also responsible for the turn-around of Pure Protein, a leading mass market brand in the Active Nutrition category. Prior to joining The Nature’s Bounty Company, Jill was the Brand Director for natural skincare line Naturopathica Holistic Health. In that role Jill was responsible for product design, marketing and distribution.
Ms. Staib serves on the Global Board of Advisors for Vitamin Angels and the Advisory Board of the J.E.D.I Collaborative.
Ms. Staib holds the following FINRA Registrations: Series 79 and 63.
Dr. Marielle Weintraub is the Director of Scientific Strategy for Eurofins Supplements & OTC Testing in Madison, WI. In this role, Dr. Weintraub is tasked with supporting clients with development of testing programs, for OTC and personal care products as well as dietary supplements and food. Prior to returning to Eurofins in 2022, Dr. Weintraub spent three years in product development.
Dr. Weintraub is very active in many OTC, dietary supplement and natural product industry trade associations. She participates on Expert Review Panels and Working Groups for AOAC International's-Cannabis Analytic Science Programs, is a member for CHPA's Quality and Manufacturing of Dietary Supplements and OTCs Committee. Dr. Weintraub is also a member of the American Herbal Products Association (AHPA), United Natural Products Alliance (UNPA), and actively supports the Association of Food and Drug Officials (AFDO).
Dr. Marielle Weintraub earned her M.S. and Ph.D. in Behavioral Neuroscience (Psychoneuroimmunology) focusing her research on Alzheimer’s disease pathology.
How to Register for the Conference
Register online
Phone registrations are NOT accepted.
Online registration:
- A log-in and password are required to register online
- New to CHPA? You must create a contact record first
- A log-in and password will be sent to you after creating a contact record.
Rates
- $3,275 Member Early-Bird Registration Fee (before January 10, 2025)
- $3,775 Member Standard Registration Fee (after January 10, 2025)
- $5,495 Nonmember Registration Fee
- $300 *Guest Fee - *One guest per member registrant is allowed. A spouse, friend or family member of the attendee who is over the age of 18 is considered a guest (or non-business affiliate). Members of an organization or prospects are not considered guests and must register at the appropriate member or nonmember fee listed above.
- $395 Golf Tournament Registration Fee
- $50 Fun Run Registration Fee (tax-deductible donation to Health in Hand Foundation)
- $325 HEB Store Tour is offered to a maximum of 50 SLS attendees. Tour led by H-E-B team in the heart of a local store in San Antonio. Shuttle to and from La Cantera Resort Spa provided. Reception with H-E-B executives to follow tour. All H-E-B activities to take place on Wednesday, March 19 immediately following the completion of SLS programming. 2 people per company then waitlist as space allows. First come, first served.
- $100 Pickleball Tournament Registration Fee
Cancellation Policy
Cancellations received by February 7, 2025, will receive a full refund. Cancellations received after February 7, 2025 will result in the forfeiture of the entire registration fee. Substitutions are always accepted.
Registration & Logistics Questions
Hotel & Travel Information
Hotel Information:
La Cantera Resort & Spa
16641 La Cantera Pkwy,
San Antonio, TX 78256
(210) 558-6500
Reservations
CHPA has a room block at the La Cantera Resort & Spa
- The CHPA 2025 Group Rate is $359.00 plus $19 resort fee and tax.
- This discounted rate is available until 3:00 p.m. Friday, February 21, 2025, or sooner if the room block sells out. Don't delay, make your arrangements today.
Check-In and Check-Out
Check-in: 4:00 p.m.
Check-out: 11:00 a.m.
Cancellation Policy
Hotel Cancellations must be received 72 hours prior to your arrival date to avoid a penalty of one night’s room and tax.
Hotel Amenities
Please visit the hotel website for a full list of amenities and features.
Travel Logistics:
Airport Information
San Antonio International Airport International Airport is approximately 15 miles/20 -30 minutes from La Cantera Resort & Spa.
Ground Transportation
This hotel does not provide airport shuttle services.
Alternate transportation:
- Private Car Service
- Limousine/Van Service
- Estimated taxi fare: $30-40 USD (one way)
Hotel Parking
- Valet Parking on property only for $40 per day.
- Self-parking: 1-4 hours: $7 | 4-8 hours: $13 | 8-24 hours: $20
Sponsorship
2025 SLS Sponsorship Prospectus
Leverage your presence at CHPA's Self-Care Leadership Summit (SLS) - the annual gathering of consumer healthcare decision-makers! The energy and impact of SLS is due in large part to our sponsors, who bring the commitment, thought leadership and generosity that make for meaningful engagement over the course of the meeting.
Spotlight your unique capabilities with a west-coast inspired activation: Tequila Tasting, Live Music, and Custom Cowboy Hat opportunities are still available!
View the 2025 SLS Sponsorship Prospectus & contact Carla Stillwagon to make your capabilities shine.
Ivan D. Combe Lifetime Achievement Award
The Ivan D. Combe Lifetime Achievement Award is CHPA’s highest honor and aims to recognize a leader whose legacy has inspired their peers, employees, and the broader consumer healthcare community. This award is bestowed upon a crusader within our industry, who has made significant contributions in the realms of Business Excellence, Commitment to the Association and Industry, and Giving Back to the Community.
Please contact Robyn Reese with questions about the Ivan D. Combe Lifetime Achievement Award.